Tigecycline Accord (tigecycline)
Generic
- Region
- 🇪🇺 EU
- Active substance
- tigecycline
- Company
- Accord Healthcare Ltd
- Status
- Application withdrawn
- Therapeutic area
- Soft Tissue Infections
- Designations
- Generic
- Application
- EMEA/H/C/004419
- ATC
- J01AA12
- Official record
- www.ema.europa.eu
Indication
Treatment of: - complicated skin and soft tissue infections, excluding diabetic foot infections - complicated intra-abdominal infections Tygacil should be used only in situations where it is known or suspected that other alternatives are not suitable
Regulatory milestones
No milestones recorded in the last year.
Same substance in other markets
- 🇪🇺 Tygacil Authorised · Pfizer Europe MA EEIG
- 🇪🇺 Tigecycline Accord Authorised · Accord Healthcare S.L.U.
Follow Tigecycline Accord
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.